24/7 Market News Snapshot 03 July, 2025 – Olo Inc. (NYSE:OLO)

July 3, 2025

DENVER, Colo., 03 July, 2025 (www.247marketnews.com) – (NYSE:OLO) are discussed in this article.
Olo Inc. (OLO) is witnessing significant market momentum, opening at $8.973 today and climbing to a high of $10.114, marking a remarkable increase of 13.51%. This rise comes after a previous close of $8.910, reflecting robust bullish sentiment among investors. The trading volume has reached 13.61 million shares, indicating a surge in interest and engagement with the stock. Analysts suggest that this movement could be influenced by favorable market conditions or recent company developments. Technical indicators point towards strengthening trends for the stock; however, ongoing monitoring will be crucial to evaluate the sustainability of this growth and identify potential resistance levels moving forward.

Concurrently, Zhengye Biotechnology Holdings Limited has released its financial results for the fiscal year ending December 31, 2024, revealing strategic adjustments aimed at fostering long-term growth in a challenging market landscape. The company reported net revenues of approximately RMB186.4 million (US$25.5 million), down 12% from RMB211.7 million (US$29.1 million) in the prior year, driven largely by a deliberate reduction in swine vaccine sales to lessen dependence on a concentrated customer segment. Co-CEO Mr. Songlin Song stated, “We believe this proactive measure will ultimately support our long-term growth initiatives.”

In addition to customer diversification, Zhengye has intensified its investments in research and development, successfully completing clinical trials for two pet vaccines targeting cats and dogs. This positions the company to penetrate the growing pet vaccine market in China. Furthermore, the receipt of Category I New Veterinary Drug Certificates for two innovative vaccines highlights Zhengye’s commitment to enhancing its R&D capabilities.

Co-CEO Mr. Aiden Han emphasized the significance of their recent Nasdaq listing as a pivotal step toward global expansion, focusing on boosting international sales and distribution networks. Despite facing near-term challenges reflected in a drop in net income to RMB13.5 million (US$1.8 million), the leadership team remains positive about the strategic direction taken to enhance stakeholder value and ensure sustainable growth in the veterinary vaccine sector.

Related news for (OLO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.